News from CTI A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 06, 2015, 16:01 ET
CTI BioPharma Corp. Logo

CTI BioPharma Reports Second Quarter 2015 Financial Results

 CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today reported financial results for the second quarter ended June 30, 2015. "The significant...

Jul 28, 2015, 01:30 ET
CTI BioPharma Corp. Logo

CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015

CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that it plans to report its second quarter 2015 financial results on Thursday, August 6,...

Jul 27, 2015, 01:30 ET
Bruce Seeley, Executive Vice President and Chief Commercial Officer of CTI BioPharma

CTI BioPharma Appoints Bruce J. Seeley As Executive Vice President and Chief Commercial Officer

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the appointment of Bruce J. Seeley as Executive Vice President and Chief...

Jun 15, 2015, 01:30 ET

Tosedostat In Combination With Low Dose Cytarabine Achieves Primary Endpoint In Phase 2 Study In Elderly Patients With AML

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced findings from an investigator-sponsored Phase 2 trial in patients...

Jun 12, 2015, 03:30 ET

Pacritinib Phase 3 Study Shows Positive Results In Patient Reported Outcomes Measuring Quality Of Life In Patients With Myelofibrosis

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxter International's BioScience business (NYSE: BAX) today announced new...

Jun 10, 2015, 01:30 ET

CTI BioPharma Amends Loan Agreement

 CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today announced that it has amended its existing loan agreement with Hercules Technology Growth...

Jun 10, 2015, 01:30 ET

CTI BioPharma And Baxter Announce Patient-Reported Outcomes (PROs) From Pacritinib Phase 3 In Patients With Myelofibrosis To Be Presented In Late-Breaking Session At EHA

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxter International's BioScience business (NYSE:BAX) today announced that Patient...

May 30, 2015, 07:30 ET
CTI BioPharma Corp. Logo

Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxter International's Bioscience business (NYSE:BAX) today announced data from...

May 06, 2015, 16:01 ET

CTI BioPharma Reports First Quarter 2015 Financial Results

 CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2015. "After reporting...

Apr 23, 2015, 01:30 ET

CTI BioPharma to Report First Quarter 2015 Financial Results on May 6, 2015

CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that it plans to report its first quarter 2015 financial results on Wednesday, May 6,...

Apr 22, 2015, 01:30 ET
CTI BioPharma Corp. Logo

CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be Presented in Late-Breaking Session at ASCO

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxter International Inc. (NYSE:BAX) today announced that data from the...

Mar 16, 2015, 02:30 ET

CTI BioPharma Announces Publication In Blood Of Phase 2 Results Of Pacritinib In Patients With Myelofibrosis

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that results of a Phase 2 study of pacritinib, in patients with...

Mar 12, 2015, 16:01 ET

CTI BioPharma Reports Fourth Quarter And Full Year 2014 Financial Results

 CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today reported financial results for the fourth quarter and full year ended December 31, 2014....

Mar 09, 2015, 07:00 ET
CTI BioPharma Corp. Logo

CTI BioPharma And Baxter Announce Positive Top-Line Results From Phase 3 Persist-1 Trial Of Pacritinib For Patients With Myelofibrosis

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxter International Inc. (NYSE:BAX) today announced positive top-line results...

Mar 06, 2015, 20:30 ET

CTI BioPharma to Host Conference Call and Webcast on March 9

 CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that its management plans to host a conference call and webcast on Monday, March 9...

Feb 26, 2015, 01:30 ET

CTI BioPharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 12, 2015

CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that it plans to report its fourth quarter and full year 2014 financial results on...

Feb 03, 2015, 01:30 ET

CTI BioPharma Announces Independent DMC Recommendation to Continue GOG-0212 Phase 3 Study of OPAXIO™ as Maintenance Therapy in Ovarian Cancer, an NRG Oncology/GOG Study

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that the Gynecologic Oncology Group, now part of NRG Oncology,...

Jan 12, 2015, 01:30 ET

CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) announced today the appointment of Alan K. Burnett, M.D., to serve as the strategic...

Jan 08, 2015, 01:30 ET

CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced an overview of recent progress for its drug portfolio in addition to...

Dec 09, 2014, 01:30 ET

CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells

CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced data showing treatment with pacritinib, an investigational oral multikinase...